NCT05429684 Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer Status UNKNOWN Phase PHASE3
NCT05306340 A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05293964 Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05252585 A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML) Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05188118 Rapid Sequencing of Approved Therapies in Patients With Metastatic or Unresectable Clear Cell Renal Cell Carcinoma Status COMPLETED Phase EARLY_PHASE1
NCT05124431 Anlotinib Plus Everolimus as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT05108740 MAP Treatment Plan With Afinitor for Postmenopausal Women With Advanced HR+ Breast Cancer Status NO_LONGER_AVAILABLE Phase N/A
NCT05012371 Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04919226 Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04867720 Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients Status UNKNOWN Phase PHASE4
NCT04849533 Belatacept With Early Steroid Withdrawal rATG and Everolimus in Renal Transplantation (BETTER Trial) Status UNKNOWN Phase PHASE4
NCT04802759 A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT04665739 Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors Status RECRUITING Phase PHASE2
NCT04591431 The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04542733 The Efficacy of Everolimus With Reduced-dose Tacrolimus Versus Reduced-dose Tacrolimus and Leflunomide in Treatment of BK Virus Infection in Kidney Transplantation Recipient Status ACTIVE_NOT_RECRUITING Phase NA
NCT04485559 Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021) Status RECRUITING Phase PHASE1
NCT04355858 Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer Status UNKNOWN Phase PHASE2
NCT04258423 Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function Status TERMINATED Phase PHASE3